Sector OSE Immunotherapeutics Börse Stuttgart
Stocks
6OP
FR0012127173
Biotechnology & Medical Research
|
Real-time Estimate
Tradegate
23:56:03 22/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.594 EUR | +0.31% |
|
-4.43% | -48.74% |
| 09-21 | OSE Immunotherapeutics SA(ENXTPA:OSE) dropped from S&P Global BMI Index | CI |
| 09-09 | OSE Immunotherapeutics: first patient treated in a Phase 2 study |  |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.55% | +4.77% | -4.25% | +12.47% | +4.65% | +4.07% | +32.02% | -25.69% | +204.88% | 46.68B | |
| +0.35% | +0.27% | +3.91% | +61.14% | +19.96% | +43.97% | +36.06% | +4.10% | +246.10% | 44.42B | |
| +0.10% | -5.99% | -8.98% | +16.15% | +141.79% | +333.65% | +541.94% | +505.99% | - | 41.32B | |
| +0.65% | +6.09% | -1.17% | +35.25% | +21.00% | +8.82% | +92.89% | -5.30% | +1,078.99% | 41.58B | |
| -1.60% | -0.17% | -7.18% | +4.82% | +3.55% | +9.73% | +43.63% | -21.19% | +131.13% | 30.14B | |
| +0.72% | +1.20% | +1.28% | +37.81% | +11.80% | +26.07% | +158.75% | +229.18% | +1,996.66% | 17.42B | |
| +0.31% | -1.60% | -6.36% | +3.48% | - | - | - | - | - | 15.6B | |
| +1.15% | +9.42% | +8.40% | +26.30% | +26.54% | +26.21% | +42.84% | -37.55% | +97.23% | 15.54B | |
| -1.40% | +11.78% | +16.31% | +60.84% | +30.33% | -10.38% | - | - | - | 14.08B | |
| +1.98% | +4.62% | -4.38% | +57.24% | +43.12% | +85.52% | +43.02% | -36.04% | +244.13% | 13.32B | |
| -1.33% | -2.43% | -3.01% | +19.56% | -7.66% | -1.49% | -32.81% | -38.68% | +120.01% | 13.08B | |
| +0.14% | +0.31% | +0.24% | +30.49% | +23.39% | +36.81% | +4.64% | -45.54% | +165.05% | 11.36B | |
| -1.48% | +4.24% | -7.34% | +95.77% | +56.38% | +26.99% | +61.97% | -54.74% | - | 11.35B | |
| +3.71% | +7.41% | +0.40% | +22.21% | +56.20% | +138.27% | +594.51% | +94.93% | - | 9.78B | |
| +0.13% | +1.47% | -5.95% | +26.50% | +66.61% | +125.57% | +750.47% | +840.63% | +806.64% | 9.38B | |
| -4.69% | -13.30% | -15.13% | +1.59% | -28.24% | +23.08% | +430.06% | +173.42% | +872.97% | 9.06B | |
| -2.32% | +3.46% | +5.19% | +21.14% | -7.15% | -8.70% | -0.11% | -28.08% | +41.11% | 9.26B | |
| +0.67% | -3.37% | -17.85% | -0.34% | +2.58% | +525.61% | +1,299.79% | +0.89% | - | 8.34B | |
| +0.82% | +1.58% | -14.06% | -2.28% | +46.46% | +138.81% | +82.59% | +325.97% | - | 7.68B | |
| Average | +0.03% | +1.15% | -3.15% | +27.90% | +28.41% | +85.14% | +246.01% | +110.72% | +500.41% | 19.44B | |
| Weighted average by Cap. | +0.34% | +1.25% | -2.58% | +28.86% | +32.78% | +77.05% | +186.12% | +96.99% | +490.57% |
- Stock Market
- Stocks
- OSE Stock
- 6OP Stock
- Sector OSE Immunotherapeutics
Select your edition
All financial news and data tailored to specific country editions
